Renaissance Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-99,572	Closed	-$3.7M	–	243
2024 Q4	$3.7M	Buy	99,572 +29,696	+42%	+$1.36M	0.15%	120
2024 Q3	$3.39M	Buy	69,876 +4,858	+7%	+$213K	0.14%	118
2024 Q2	$2.6M	Buy	65,018 +5,616	+9%	+$233K	0.1%	171
2024 Q1	$2.61M	Buy	59,402 +10,983	+23%	+$567K	0.1%	167
2023 Q4	$3.01M	Buy	48,419 +2,923	+6%	+$154K	0.12%	118
2023 Q3	$2.09M	Buy	45,496 +887	+2%	+$48.4K	0.1%	145
2023 Q2	$2.56M	Sell	44,609 -2,250	-5%	-$99.7K	0.11%	113
2023 Q1	$1.76M	Buy	46,859 +2,263	+5%	+$74.2K	0.08%	146
2022 Q4	$1.25M	Buy	44,596 +232	+0.5%	+$6.74K	0.06%	183
2022 Q3	$1.25M	Buy	44,364 +1,425	+3%	+$46.5K	0.07%	164
2022 Q2	$1.49M	Sell	42,939 -5,894	-12%	-$210K	0.08%	120
2022 Q1	$1.75M	Sell	48,833 -14,726	-23%	-$418K	0.08%	118
2021 Q4	$1.48M	Buy	63,559 +2,740	+5%	+$56K	0.06%	134
2021 Q3	$1.16M	Sell	60,819 -1,008	-2%	-$19.7K	0.05%	151
2021 Q2	$1.25M	Buy	+61,827	New	+$1.16M	0.05%	139